Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan 1;78(1):65-76.
doi: 10.1093/nutrit/nuz027.

The conundrum of dietary antioxidants in cancer chemotherapy

Roghayeh Ilghami  1 , Abolfazl Barzegari  1 , Mohammad Reza Mashayekhi  1 , Didier Letourneur  1 , Michel Crepin  1 , Graciela Pavon-Djavid  1
Affiliations
Review

The conundrum of dietary antioxidants in cancer chemotherapy

Roghayeh Ilghami et al. Nutr Rev. .

Abstract

Although chemotherapy succeeds in reducing tumor burden, the efficacy is limited due to acquired drug resistance and often irreparable side effects. Studies show that antioxidants may influence the response to chemotherapy and its side effects, although their use remains controversial. The evidence shows that some chemo-drugs induce oxidative stress and lead to normal tissue apoptosis and the entry of cancer cells to a dormant G0 state. Through the suppression of oxidative stress, antioxidants could protect normal cells and bring the tumor out of dormancy so as to expose it to chemotherapies. This review is focused on the redox biology of cancer/normal cells and association of reactive oxygen species with drug resistance, cancer dormancy, and side effects. To this end, evidence from cellular, animal, and clinical studies is provided to better understand the conundrum of dietary antioxidants in cancer chemotherapy.

Keywords: antioxidants; cancer chemotherapy; carotenoids; oxidative stress; side effect.

PubMed Disclaimer